All In MedTech

FDA Clearance Tracker · P150004-S040

Axium Neurostimulator System

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Jan 21, 2021 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Jan 21, 2021

Approved

Time to decision

234 days

Received Jun 1, 2020. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track No User Fee

Device class

Class III

The decision

FDA number
P150004-S040
Device name
Axium Neurostimulator System
Applicant location
Plano, TX
Received
Jun 1, 2020
Decided
Jan 21, 2021
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Postapproval Study Protocol
Original approval
P150004

Device type

Device class
Class III

Every decision under product code PMP

FDA's approval statement

As written in FDA's record.

Approval of the revised protocol for the post-approval study (PAS0 protocol.

Source documents

Other decisions for ABBOTT MEDICAL

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

5 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.